Ignite Creation Date:
2024-05-06 @ 3:17 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02259114
Status:
COMPLETED
Last Update Posted:
2021-01-26
First Post:
2014-10-03
Brief Title:
A Dose-Finding Study of Birabresib MK-8628 a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal BET Proteins in Adults With Selected Advanced Solid Tumors MK-8628-003
Sponsor:
Oncoethix GmbH a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Oncoethix GmbH a subsidiary of Merck Co Inc Rahway New Jersey USA
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pancreatic Ductal Adenocarcinoma |
| NUT Midline Carcinoma |
| Triple Negative Breast Cancer |
| Non-small Cell Lung Cancer With Rearranged ALK GeneFusion Protein or KRAS Mutation |
| Castrate-resistant Prostate Cancer |
| CRPC |
Keywords: